Phase II: rapid array diagnosis of congenital heart defects (RAD4CHD) using allele diagnostics rapid array chromosomal microarray strategy
Ended Project Grant Awarded Last action
- Award ID
- R44HL145937
- Recipient
-
Allele Diagnostics Inc. UEI CE87SF5P6NN1
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,014,688
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Funding
-
- $2,246,124.00 Federal
- $768,564.00 Non-federal
- Place of performance
- Washington, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $768,564 | $0 | |
| Amendment | $768,564 | $768,564 | |
| Original award | $708,996 | $0 |
Quick answers
Who received award R44HL145937?
R44HL145937 was awarded to Allele Diagnostics Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on March 1, 2019.
How much is award R44HL145937 worth?
$3,014,688 has been obligated on R44HL145937: $2,246,124 in federal funding and $768,564 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award